Bioindustry Ethics Bioindustry Ethics

Bioindustry Ethics

David L. Finegold and Others
    • $57.99
    • $57.99

Publisher Description

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

GENRE
Professional & Technical
RELEASED
2005
19 July
LANGUAGE
EN
English
LENGTH
384
Pages
PUBLISHER
Elsevier Science
SELLER
Elsevier Ltd.
SIZE
8.8
MB

More Books Like This

Value Shift: Why Companies Must Merge Social and Financial Imperatives to Achieve Superior Performance Value Shift: Why Companies Must Merge Social and Financial Imperatives to Achieve Superior Performance
2002
Stewards of the Future Stewards of the Future
2021
The Responsibility Revolution The Responsibility Revolution
2010
The Global Corporation The Global Corporation
2013
HBR's 10 Must Reads 2018 HBR's 10 Must Reads 2018
2017
5 Years of Must Reads from HBR: 2021 Edition (5 Books) 5 Years of Must Reads from HBR: 2021 Edition (5 Books)
2020